Rashed Dewan
Director of Finance/CFO bij PROFOUND MEDICAL CORP.
Vermogen: 202 562 $ op 31-03-2024
Profiel
Rashed Dewan is currently working as the Chief Financial Officer at Profound Medical Corp.
He started this position in 2022.
Previously, he worked as a Controller at Profound Medical, Inc. Mr. Dewan completed his undergraduate degree at the University of Southern California.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
PROFOUND MEDICAL CORP
0.10% | 15-08-2023 | 23 747 ( 0.10% ) | 202 562 $ | 31-03-2024 |
Actieve functies van Rashed Dewan
Bedrijven | Functie | Begin |
---|---|---|
PROFOUND MEDICAL CORP. | Director of Finance/CFO | 03-03-2022 |
Eerdere bekende functies van Rashed Dewan
Bedrijven | Functie | Einde |
---|---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Comptroller/Controller/Auditor | - |
Opleiding van Rashed Dewan
University of Southern California | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
PROFOUND MEDICAL CORP. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Profound Medical, Inc.
Profound Medical, Inc. Medical SpecialtiesHealth Technology Profound Medical, Inc. develops and commercializes a unique, minimally invasive treatment for prostate cancer. Its novel technology combines Magnetic Resonance Imaging (MRI) guidance and ultrasound energy to deliver thermal ablative therapy to the prostate gland. The firm deliveres via a trans-urethral approach, the technique combines the image quality of MRI with thermal ultrasound as the treatment tool. Its method of prostate cancer treatment affords highly accurate and precise treatment within the prostate gland in a short time span in an outpatient setting. The company was founded in June 2008 by Michael Bronskill, Rajiv Chopra and Paul Chipperton and is headquartered in Toronto, Canada. | Health Technology |